Vascular function is further impaired in subjects aged 80 years or older.
Aging
Brachial-ankle pulse wave velocity
Flow-mediated vasodilation
Nitroglycerine-induced vasodilation
Vascular function
Journal
Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
03
02
2020
accepted:
10
03
2020
revised:
26
02
2020
pubmed:
10
4
2020
medline:
7
10
2021
entrez:
10
4
2020
Statut:
ppublish
Résumé
The percentage of people aged 80 years or older in Japan has been increasing. The purpose of this study was to investigate the association between vascular functions and aging in the elderly population and to clarify the characteristics of vascular functions in subjects aged 80 years or older. We measured flow-mediated vasodilation (FMD), nitroglycerine-induced vasodilation (NID), and brachial-ankle pulse wave velocity (baPWV) in 737 subjects aged 60 years or older who visited the outpatient clinic at Hiroshima University Hospital. FMD and NID were significantly lower in subjects aged 80 years or older than in subjects aged 60-69 years or in subjects aged 70-79 years (1.9 ± 2.0% vs. 2.9 ± 2.6% and 2.7 ± 2.6%, P = 0.008 and P = 0.03, respectively and 8.6 ± 5.1% vs. 12.1 ± 5.6% and 11.2 ± 5.5%, P < 0.001 and P < 0.001, respectively). baPWV was significantly higher in subjects aged 80 years or older than in subjects aged 60-69 years or in subjects aged 70-79 years (1978 ± 452 cm/s vs. 1724 ± 319 cm/s and 1811 ± 318 cm/s, P < 0.001 and P < 0.001, respectively). Age over 80 years was significantly associated with lower FMD (OR, 2.02; 95% CI, 1.19-3.42; P = 0.01), lower NID (OR, 3.62; 95% CI, 2.13-6.17; P < 0.001), and higher baPWV (OR, 3.48; 95% CI, 1.99-6.08; P < 0.001) after adjustment for other cardiovascular risk factors. Vascular functions, including endothelial function, vascular smooth muscle function, and arterial stiffness, were shown to be further impaired in subjects aged 80 years or older, suggesting that vascular functions continue to be impaired throughout life with aging.
Identifiants
pubmed: 32269307
doi: 10.1038/s41440-020-0435-z
pii: 10.1038/s41440-020-0435-z
doi:
Substances chimiques
Nitroglycerin
G59M7S0WS3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
914-921Références
Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, et al. Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961-2009). Circulation. 2013;128:1198–205.
doi: 10.1161/CIRCULATIONAHA.113.002424
Wei JY. Age and the cardiovascular system. N Engl J Med. 1992;327:1735–9.
doi: 10.1056/NEJM199212103272408
Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement—a survey of 12 517 subjects. Atherosclerosis. 2003;166:303–9.
doi: 10.1016/S0021-9150(02)00332-5
Tomiyama H, Kohro T, Higashi Y, Takase B, Suzuki T, Ishizu T, et al. Reliability of measurement of endothelial function across multiple institutions and establishment of reference values in Japanese. Atherosclerosis. 2015;242:433–42.
doi: 10.1016/j.atherosclerosis.2015.08.001
Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253–390.
doi: 10.1038/hr.2013.80
American Diabetes Association. Clinical practice recommendations 1999. Diabetes Care 1999;22:S1–114.
doi: 10.2337/diacare.22.1.1
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.
doi: 10.1001/jama.285.19.2486
Nakamura M, Yamashita T, Yajima J, Oikawa Y, Sagara K, Koike A, et al. Brachial-ankle pulse wave velocity as a risk stratification index for the short-term prognosis of type 2 diabetic patients with coronary artery disease. Hypertens Res. 2010;33:1018–24.
doi: 10.1038/hr.2010.126
Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340:115–26.
doi: 10.1056/NEJM199901143400207
Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–8.
doi: 10.1253/circj.CJ-08-1102
Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997–1000.
doi: 10.1016/S0140-6736(89)91013-1
Vanhoutte PM. Endothelium and control of vascular function. State of the Art lecture. Hypertension. 1989;13:658–67.
doi: 10.1161/01.HYP.13.6.658
Higashi Y, Kihara Y, Noma K. Endothelial dysfunction and hypertension in aging. Hypertens Res. 2012;35:1039–47.
doi: 10.1038/hr.2012.138
Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study. Heart. 2013;99:1837–42.
doi: 10.1136/heartjnl-2013-304739
Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468–74.
doi: 10.1016/0735-1097(94)90141-4
Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation. 2004;109:613–9.
doi: 10.1161/01.CIR.0000112565.60887.1E
Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 1998;32:123–7.
doi: 10.1016/S0735-1097(98)00206-X
Raitakari OT, Seale JP, Celermajer DS. Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol. 2001;87:217–9.
doi: 10.1016/S0002-9149(00)01321-7
Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, et al. Nitroglycerine-induced vasodilation for assessment of vascular function: a comparison with flow-mediated vasodilation. Arterioscler Thromb Vasc Biol. 2013;33:1401–8.
doi: 10.1161/ATVBAHA.112.300934
Munzel T, Afanas’ev IB, Kleschyov AL, Harrison DG. Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol. 2002;22:1761–8.
doi: 10.1161/01.ATV.0000034022.11764.EC
Liu S, Ma X, Gong M, Shi L, Lincoln T, Wang S. Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Free Radic Biol Med. 2007;42:852–63.
doi: 10.1016/j.freeradbiomed.2006.12.025
Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Investig. 2004;113:482–9.
doi: 10.1172/JCI200419267
Moon SK, Thompson LJ, Madamanchi N, Ballinger S, Papaconstantinou J, Horaist C, et al. Aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells. Am J Physiol Heart Circ Physiol. 2001;280:H2779–88.
doi: 10.1152/ajpheart.2001.280.6.H2779
Fry JL, Al Sayah L, Weisbrod RM, Van Roy I, Weng X, Cohen RA, et al. Vascular smooth muscle sirtuin-1 protects against diet-induced aortic stiffness. Hypertension. 2016;68:775–84.
doi: 10.1161/HYPERTENSIONAHA.116.07622
Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, et al. Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens. 2005;19:401–6.
doi: 10.1038/sj.jhh.1001838
Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27:2022–7.
doi: 10.1097/HJH.0b013e32832e94e7
Najjar SS, Scuteri A, Lakatta EG. Arterial aging—is it an immutable cardiovascular risk factor? Hypertension. 2005;46:454–62.
doi: 10.1161/01.HYP.0000177474.06749.98
Nurminskaya MV, Belkin AM. Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol. 2012;294:1–97.
doi: 10.1016/B978-0-12-394305-7.00001-X
Santhanam L, Tuday EC, Webb AK, Dowzicky P, Kim JH, Oh YJ, et al. Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res. 2010;107:117–25.
doi: 10.1161/CIRCRESAHA.109.215228
Jung SM, Jandu S, Steppan J, Belkin A, An SS, Pak A, et al. Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice. Am J Physiol Heart Circ Physiol. 2013;305:H803–10.
doi: 10.1152/ajpheart.00103.2013
Steppan J, Bergman Y, Viegas K, Armstrong D, Tan S, Wang H, et al. Tissue transglutaminase modulates vascular stiffness and function through crosslinking-dependent and crosslinking-independent functions. J Am Heart Assoc. 2017;6:e004161.
doi: 10.1161/JAHA.116.004161
Laurent S, Boutouyrie P, Cunha PG, Lacolley P, Nilsson PM. Concept of extremes in vascular aging from early vascular aging to supernormal vascular aging. Hypertension. 2019;74:218–28.
doi: 10.1161/HYPERTENSIONAHA.119.12655